|
Market Closed -
Other stock markets
|
After hours 12:51:50 | |||
| 235.60 EUR | -0.63% |
|
235.30 | -0.13% |
| 01:10am | Antengene Receives $60 Million Milestone in UCB Licensing Deal | MT |
| 07-09 | UK Life Sciences Hits GBP3 Billion Investment Milestone | MT |
Main competitors
| Consensus | Analysts' target price evolution (4 months) | Analysts' recommendations evolution (4 months) | Financial estimates divergence | Analysts' Target price divergence | Average Target P. | Objective/dr gap | Nbr of analysts | ||
|---|---|---|---|---|---|---|---|---|---|
 | 287.95 | +21.45% | 19 | ||||||
| 822.45 | +23.77% | 28 | ||||||
| 2,052,158.8 | +47.11% | 24 | ||||||
| 96.64 | +13.06% | 16 | ||||||
| 222.83 | +11.89% | 31 | ||||||
| 48.26 | -29.31% | 19 | ||||||
| 111.45 | -4.5% | 22 | ||||||
| 101.33 | +30.61% | 25 | ||||||
| 486.67 | +3.28% | 12 | ||||||
| 104.24 | +21.37% | 22 | ||||||
| 276.56 | +18.29% | 21 | ||||||
| 458,000 | +41.36% | 5 | ||||||
| 87.69 | +48.33% | 26 | ||||||
| 358.11 | -2.1% | 9 | ||||||
| - | - | 61.5 | +16.47% | 1 | ||||
| 14.4 | +61.68% | 12 | ||||||
| 72.5 | +9.07% | 2 | ||||||
| 30.05 | +92.32% | 9 | ||||||
| 77.7 | -14.27% | 10 | ||||||
| - | - | 40.3 | +40.22% | 1 | ||||
| Average | 125,672.97 | +22.50% | 16 | ||||||
| Weighted average by Cap. | 223,966.71 | +19.59% | 20 |
- Stock Market
- Stocks
- UCB Stock
- Sector UCB
- Sector consensus
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
